Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom
<p><strong>Background: </strong>The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant has been replaced by the highly transmissible Omicron BA.1 variant, and subsequently by Omicron BA.2. It is important to understand how these changes in dominant...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Oxford University Press
2022
|
| _version_ | 1797109434334314496 |
|---|---|
| author | Vihta, K Pouwels, K Peto, T Pritchard, E House, T Studley, R Cook, D Diamond, I Crook, D Clifton, D Matthews, P Stoesser, N Eyre, D Walker, AS |
| author_facet | Vihta, K Pouwels, K Peto, T Pritchard, E House, T Studley, R Cook, D Diamond, I Crook, D Clifton, D Matthews, P Stoesser, N Eyre, D Walker, AS |
| author_sort | Vihta, K |
| collection | OXFORD |
| description | <p><strong>Background: </strong>The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant has been replaced by the highly transmissible Omicron BA.1 variant, and subsequently by Omicron BA.2. It is important to understand how these changes in dominant variants affect reported symptoms, while also accounting for symptoms arising from other cocirculating respiratory viruses.</p>
<p><strong>Methods: </strong>In a nationally representative UK community study, the COVID-19 Infection Survey, we investigated symptoms in polymerase chain reaction (PCR)–positive infection episodes versus PCR-negative study visits over calendar time, by age and vaccination status, comparing periods when the Delta, Omicron BA.1, and BA.2 variants were dominant.</p>
<p><strong>Results: </strong>Between October 2020 and April 2022, a total of 120 995 SARS-CoV-2 PCR-positive episodes occurred in 115 886 participants, with 70 683 (58%) reporting symptoms. The comparator comprised 4 766 366 PCR-negative study visits (483 894 participants), with symptoms reported at 203 422 visits (4%). Symptom reporting in PCR-positive infections varied over time, with a marked reduction in loss of taste/smell as Omicron BA.1 dominated, which was maintained with BA.2 (44% symptomatic infections reporting loss of taste/45% symptomatic infections reporting loss of smell on 17 October 2021, 16%/13% 2 January 2022, 15%/12% 27 March 2022). Cough, fever, shortness of breath, myalgia, fatigue/weakness, and headache also decreased after Omicron BA.1 dominated, but sore throat increased, the latter to a greater degree than concurrent increases in PCR-negative visits. Fatigue/weakness increased again after BA.2 dominated, although to a similar degree to concurrent increases in PCR-negative visits. Symptoms were consistently more common in adults aged 18–65 years than in children or older adults.</p>
<p><strong>Conclusions: </strong>Increases in sore throat (also common in the general community), along with a marked reduction in loss of taste/smell, make Omicron harder to detect with symptom-based testing algorithms, with implications for institutional and national testing policies.</p> |
| first_indexed | 2024-03-07T07:41:49Z |
| format | Journal article |
| id | oxford-uuid:04f31a2e-e088-4c9c-8e9e-28e43683557d |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:41:49Z |
| publishDate | 2022 |
| publisher | Oxford University Press |
| record_format | dspace |
| spelling | oxford-uuid:04f31a2e-e088-4c9c-8e9e-28e43683557d2023-05-03T07:00:55ZOmicron-associated changes in SARS-CoV-2 symptoms in the United KingdomJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:04f31a2e-e088-4c9c-8e9e-28e43683557dEnglishSymplectic ElementsOxford University Press2022Vihta, KPouwels, KPeto, TPritchard, EHouse, TStudley, RCook, DDiamond, ICrook, DClifton, DMatthews, PStoesser, NEyre, DWalker, AS<p><strong>Background: </strong>The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant has been replaced by the highly transmissible Omicron BA.1 variant, and subsequently by Omicron BA.2. It is important to understand how these changes in dominant variants affect reported symptoms, while also accounting for symptoms arising from other cocirculating respiratory viruses.</p> <p><strong>Methods: </strong>In a nationally representative UK community study, the COVID-19 Infection Survey, we investigated symptoms in polymerase chain reaction (PCR)–positive infection episodes versus PCR-negative study visits over calendar time, by age and vaccination status, comparing periods when the Delta, Omicron BA.1, and BA.2 variants were dominant.</p> <p><strong>Results: </strong>Between October 2020 and April 2022, a total of 120 995 SARS-CoV-2 PCR-positive episodes occurred in 115 886 participants, with 70 683 (58%) reporting symptoms. The comparator comprised 4 766 366 PCR-negative study visits (483 894 participants), with symptoms reported at 203 422 visits (4%). Symptom reporting in PCR-positive infections varied over time, with a marked reduction in loss of taste/smell as Omicron BA.1 dominated, which was maintained with BA.2 (44% symptomatic infections reporting loss of taste/45% symptomatic infections reporting loss of smell on 17 October 2021, 16%/13% 2 January 2022, 15%/12% 27 March 2022). Cough, fever, shortness of breath, myalgia, fatigue/weakness, and headache also decreased after Omicron BA.1 dominated, but sore throat increased, the latter to a greater degree than concurrent increases in PCR-negative visits. Fatigue/weakness increased again after BA.2 dominated, although to a similar degree to concurrent increases in PCR-negative visits. Symptoms were consistently more common in adults aged 18–65 years than in children or older adults.</p> <p><strong>Conclusions: </strong>Increases in sore throat (also common in the general community), along with a marked reduction in loss of taste/smell, make Omicron harder to detect with symptom-based testing algorithms, with implications for institutional and national testing policies.</p> |
| spellingShingle | Vihta, K Pouwels, K Peto, T Pritchard, E House, T Studley, R Cook, D Diamond, I Crook, D Clifton, D Matthews, P Stoesser, N Eyre, D Walker, AS Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom |
| title | Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom |
| title_full | Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom |
| title_fullStr | Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom |
| title_full_unstemmed | Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom |
| title_short | Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom |
| title_sort | omicron associated changes in sars cov 2 symptoms in the united kingdom |
| work_keys_str_mv | AT vihtak omicronassociatedchangesinsarscov2symptomsintheunitedkingdom AT pouwelsk omicronassociatedchangesinsarscov2symptomsintheunitedkingdom AT petot omicronassociatedchangesinsarscov2symptomsintheunitedkingdom AT pritcharde omicronassociatedchangesinsarscov2symptomsintheunitedkingdom AT houset omicronassociatedchangesinsarscov2symptomsintheunitedkingdom AT studleyr omicronassociatedchangesinsarscov2symptomsintheunitedkingdom AT cookd omicronassociatedchangesinsarscov2symptomsintheunitedkingdom AT diamondi omicronassociatedchangesinsarscov2symptomsintheunitedkingdom AT crookd omicronassociatedchangesinsarscov2symptomsintheunitedkingdom AT cliftond omicronassociatedchangesinsarscov2symptomsintheunitedkingdom AT matthewsp omicronassociatedchangesinsarscov2symptomsintheunitedkingdom AT stoessern omicronassociatedchangesinsarscov2symptomsintheunitedkingdom AT eyred omicronassociatedchangesinsarscov2symptomsintheunitedkingdom AT walkeras omicronassociatedchangesinsarscov2symptomsintheunitedkingdom |